Development and clinical application of the molecular diagnostic tests to select anti-cancer drugs
Development and clinical application of the molecular diagnostic tests to select anti-cancer drugs
批准号:
15590498
负责人:
MIYACHI Hayato
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Drug resistance is a major obstacle in chemotherapy of leukemia patients. Since the treatment responsiveness is different among patients, the therapy should be tailored to specific subtypes of diseases such as defined by drug resistance. To screen candidate genes putatively involved in the drug resistance, we analyzed gene expression profiling in drug-resistant leukemia cells using a commercially available cDNA microarray, Human Cancer CHIP version 3.0 (TaKaRa Biotechnology). This carries probe sets for 630 complementary DNAs designed to monitor genes of which expression is assumed to be involved in the biological process of cancer. A pair of RNA samples was extracted from trimetrexate-resistant leukemia MOLT-3 cells (MOLT-3/TMQ200) and sensitive cells, and independently fluorescence-labeled with Cy3 or Cy5 dye during reverse-transcription reaction. A sample mixture was competitively hybridized with the targets spotted onto the microarray, and a raw digital image was scanned and computed with Scan Array 4000 (General Scanning). In addition to overexpression of known genes as molecular mechanisms such as MDR1, there appeared overexpression of novel genes that are involved in DNA repair or gene transcription such as ATM. There were many down-regulated genes, including those involved in cell adhesion and intracellular signal transduction. Another experiment for gene expression analysis of MOLT-3 resistant to idarubicin showed decreased expression of topoisomerase inhibitor II alfa and increased expression of GS3955 protein (putative serine/threonine kinase). These results were confirmed by Northern blot analysis. This specific gene expression profiling comprised of those up-regulated and down-regulated may be indicative of cells with resistance to drugs, and its detection may predict the response. Gene expression profiling analysis will clarify molecular mechanisms of drug resistance by screening of novel genes and annotation that are involved in it.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Large diversity in transport-mediates resistance in human leukemia cell line CCRF-CEM established in a high concentration of leucovorin.
在高浓度亚叶酸中建立的人白血病细胞系 CCRF-CEM 中转运介导的耐药性存在很大的多样性。
DOI:
--
发表时间:
2003
期刊:
Cancer Science 94
影响因子:
--
作者:
[Asai, S., et al.]
通讯作者:
et al.
腫瘍の診断マーカーとしての遺伝子検査
基因检测作为肿瘤的诊断标志物
DOI:
--
发表时间:
2003
期刊:
臨床病理 51
影响因子:
--
作者:
[Asai, S., et al., 宮地 勇人]
通讯作者:
宮地 勇人
A competitive nucleic acid sequence -based amplification assay for the quantification of human MDR 1 transcript in leukemia cells.
基于竞争性核酸序列的扩增测定,用于定量白血病细胞中人 MDR 1 转录物。
DOI:
--
发表时间:
2004
期刊:
Clin.Chim.Acta. 342
影响因子:
--
作者:
[Hayashi, T., et al.]
通讯作者:
et al.
A competitive nucleic acid sequence-based amplification assay for the quantification of human MDR1 transcript in leukemia cells.
一种基于竞争性核酸序列的扩增测定,用于定量白血病细胞中人 MDR1 转录物。
DOI:
--
发表时间:
2004
期刊:
Clinica Chemica Acta 342
影响因子:
--
作者:
[Hayashi, T., et al.]
通讯作者:
et al.
Reversal of drug resistance mediated by hammerhead ribozyme against multidrug resisance-associated protein 1 in a human glioma cell line.
锤头核酶介导的人胶质瘤细胞系中多药耐药相关蛋白 1 介导的耐药性的逆转。
DOI:
--
发表时间:
2003
期刊:
Intern.J.Oncol. 22
影响因子:
--
作者:
[Osada H., et al.]
通讯作者:
et al.
共 9 条
Development of an evaluation method based on the elucidation of drug-resistance mechanisms of leukaemia cells through bone marrow niche cross talk
-
批准号:18K07425
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2018
-
负责人:MIYACHI Hayato
-
依托单位:
Molecular mechanisms of refractory leukemia cells in the bone marrow microenvironment
-
批准号:15K08654
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2015
-
负责人:MIYACHI Hayato
-
依托单位:
Elucidation of Molecular Mechanisms of Refractory Leukemia: Diagnostic Implications of FLT3-ITD Associated Biomarkers for Drug Resistance.
-
批准号:24590709
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.49万
-
财政年份:2012
-
负责人:MIYACHI Hayato
-
依托单位:
Elucidation of molecular mechanisms of drug-resistant leukemia through micro RNA analysis : applications to laboratory diagnostics
-
批准号:21590640
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:MIYACHI Hayato
-
依托单位:
Development of the molecular diagnostic tests for drug-resistant cancer cells based on gene expression profiling using microarray
-
批准号:17590499
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:MIYACHI Hayato
-
依托单位:
Development and clinical application of the molecular diagnostic tests for individualization of cancer chemotherapy: detection of gene polymorphism of metabolizing enzyme and expression pattern
-
批准号:12672254
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:2000
-
负责人:MIYACHI Hayato
-
依托单位:
Studies on Molecular Diagnostic Tests for Drug Resistance in Leukemia Cells: Molecular Mechanisms of Drug Resistance Analyzed through Genomic Instability and Its application to Molecular Diagnostic Tests
-
批准号:10672186
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1998
-
负责人:MIYACHI Hayato
-
依托单位:
A study on the molecular diagnosis of antifolate resistance in leukemia cells : Establishment of anti-folate-resistant cell line and elucidation of molecular mechanisms of resistance
-
批准号:07672502
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1995
-
负责人:MIYACHI Hayato
-
依托单位:
海外基金